Funding source in Global project
Year:

China Medical System Holdings Limited (91440300192191146L)

Check the details 1(25.00%)

Key Research and Development Project of Shaanxi Province (Project Number: 2023-YBSF-654)

Check the details 1(25.00%)

Self-financed

Check the details 1(25.00%)

The use of tislelizumab for therapy was funded by Beijing BeiGene Ltd

Check the details 1(25.00%)